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SHORT ABSTRACT:  
The ability of inflamed endothelium to recruit leukocytes from flow is regulated by 
mesenchymal stromal cells. We describe two in vitro models incorporating primary human cells 
that can be used to assess neutrophil recruitment from flow and examine the role that 
mesenchymal stromal cells play in regulating this process.  
 
LONG ABSTRACT:  
Stromal cells regulate the recruitment of circulating leukocytes during inflammation through 
cross-talk with neighboring endothelial cells. Here we describe two in vitro “vascular” models 
for studying the recruitment of circulating neutrophils from flow by inflamed endothelial cells. 
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A major advantage of these models is the ability to analyze each step in the leukocyte adhesion 
cascade in order, as would occur in vivo.  We also describe how both models can be adapted to 
study the role of stromal cells, in this case mesenchymal stem cells (MSC), in regulating 
leukocyte recruitment.  
 
Primary endothelial cells were cultured alone or together with human MSC in direct contact on 
Ibidi microslides or on opposite sides of a Transwell filter for 24hr. Cultures were stimulated 
with tumor necrosis factor alpha (TNFα) for 4hr and incorporated into a flow-based adhesion 
assay. A bolus of neutrophils was perfused over the endothelium for 4min. The capture of 
flowing neutrophils and their interactions with the endothelium was visualized by phase-
contrast microscopy. 
 
In both models, cytokine-stimulation increased endothelial recruitment of flowing neutrophils 
in a dose-dependent manner. Analysis of the behavior of recruited neutrophils showed a dose-
dependent decrease in rolling and a dose-dependent increase in transmigration through the 
endothelium. In co-culture, MSC suppressed neutrophil adhesion to TNFα-stimulated 
endothelium.  
 
Our flow based-adhesion models mimic the initial phases of leukocyte recruitment from the 
circulation. In addition to leukocytes, they can be used to examine the recruitment of other cell 
types, such as therapeutically administered MSC or circulating tumor cells. Our multi-layered 
co-culture models have shown that MSC communicate with endothelium to modify their 
response to pro-inflammatory cytokines, altering the recruitment of neutrophils. Further 
research using such models is required to fully understand how stromal cells from different 
tissues and conditions (inflammatory disorders or cancer) influence the recruitment of 
leukocytes during inflammation. 
  
INTRODUCTION:  
Inflammation is a protective response to microbial infection or tissue injury that requires tight 
regulation of leukocyte entry into and exit from the inflamed tissue to allow resolution1,2. Cross-
talk between endothelial cells (EC) that line blood vessels, circulating leukocytes and tissue-
resident stromal cells is essential for coordinating this process3. However, uncontrolled 
recruitment of leukocytes and their ineffective clearance underpin the development of chronic 
inflammatory diseases4. Our current understanding of leukocyte recruitment in health and 
disease is incomplete and more robust models are needed to analyze this process. 
 
The mechanisms supporting the recruitment of leukocytes from blood through vascular EC in 
post-capillary venules have been well described1,2,5. Circulating leukocytes are captured by 
specialized receptors (e.g., VCAM-1, E-selectin, P-selectin) which are up-regulated on inflamed 
endothelium. These transient interactions allow leukocytes to interact with surface bound 
chemokines and lipid-derived mediators (either endothelial or stromal in origin) that activate 
integrins expressed by leukocytes6–11. This in turn stabilizes adhesion and drives migration 
across the endothelium and into the tissue12–15. Within tissue, recruited leukocytes are 
subjected to stromal-derived agents that influence their motility, function and survival16,17. 
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Growing evidence strongly suggests that signals received at each stage of the recruitment 
process conditions leukocytes for the next. However, our understanding of leukocyte 
recruitment remains incomplete and very little is known about the components shaping 
leukocyte movement within tissue.    
 
In Birmingham we have developed several in vitro “vascular” models to study the recruitment 
of leukocytes from flow9,18,19. We now understand that vascular EC act as immediate regulators 
of leukocyte recruitment responding to changes in their local microenvironment.  Specifically, 
tissue-resident stromal cells can actively regulate the inflammatory response, in part by 
conversing with neighboring vascular EC to influence their role in recruitment3.  We have 
previously shown that various stromal cells modulate the ability of EC to support adhesion and 
migration of leukocytes in a tissue-specific manner, and that these effects become altered in 
chronic diseases13,16,20,21. Thus, stromal cells establish tissue ‘address-codes’ that define the 
context of each inflammatory response22. More recently, we have demonstrated that bone-
marrow derived MSC (BMMSC) potently down-regulate the response of EC to cytokines, leading 
to a reduction in the recruitment of both neutrophils and lymphocytes23. 
 
The mechanisms governing recruitment elucidated in vitro have largely used assays 
incorporating a single cell type (e.g. EC) or protein in isolation. However, these studies do not 
take into consideration the effects of the local tissue environment (i.e. the presence of stromal 
cells) on recruitment of leukocytes and their subsequent migration into the tissue. Here we 
describe two flow-based methods in which stromal cells, specifically mesenchymal stem cells 
(MSC), are co-cultured with EC23. Such models allow us to examine the effect of stromal cell on 
endothelial responses, in particular their ability to support leukocyte recruitment from flow.  
 
PROTOCOL:  
 
1. Isolation and culture of primary human endothelial cells and mesenchymal stem cells 
 
1.1. Isolation and culture of human umbilical vein endothelial cells (HUVEC) 
 
1.1.1. Put umbilical cord on a tray with paper towels and spray with 70% ethanol. Place in a 
tissue culture hood.Identify the vein and cannulate at both ends.Place a cable tie around the 
cannulated end to secure it.  
 
1.1.2. Wash out venous blood with PBS using a syringe. Fill syringe with air and pass through 
the vein to remove and discard the residual PBS. 
 
1.1.3. Thaw 10mg/ml collagenase type Ia and dilute 1:10 in PBS (with calcium and magnesium 
chloride) to a final concentration of 1mg/ml.Pass collagenase solution into the vein until both 
cannulae are filled. Close the clamps on cannulae at both ends. 
 
1.1.4. Cover the tray with tissue and spray with 70% ethanol. Place the cord into an incubator 
for 20min at 37oC and 5% CO2. 
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1.1.5. Take the cord out of the incubator and tighten cable ties. Massage the cord gently for 
1min. Flush out the cell suspension with 10ml PBS and collect in a 50ml centrifuge tube. 
 
1.1.6. Fill syringe with air and pass through the vein to remove any residual PBS twice, 
collecting the PBS in a 50ml centrifuge tube used in 1.1.5. Centrifuge at 400x g for 5min at room 
temperature. 
 
1.1.7. Aspirate supernatant and resuspend pellet in 1ml complete EC medium. EC medium 
consists of M199 supplemented with 35µg/ml gentamicin sulphate, 10ng/ml human epidermal 
growth factor, 1µg/ml hydrocortisone, 2.5μg/ml amphotericin B and 20% fetal calf serum. 
 
1.1.8. Add 4ml of EC medium and the EC suspension to a 25cm2 flask. Change the medium on 
the following day and then every 2 days.   
 
1.1.9. EC exhibit a cobblestone-like morphology (Figure 1Ai). For adhesion assays, EC are 
generally seeded when they reach 100% confluence (see Section 1.4.).  
 
1.2. Isolation of wharton’s jelly mesenchymal stem cells (WJMSC) from human umbilical 
cords 
 
1.2.1. Isolate Wharton’s jelly-derived MSC (WJMSC) from fresh umbilical cords or from cords 
that have already been used to isolate EC. Cut umbilical cord into 5cm long pieces. Cut each 
piece longitudinally to reveal the blood vessels (2 arteries [white, rigid] and 1 vein [yellow, 
distended]). 
 
1.2.2. Using sterile scissors and forceps remove the blood vessels and discard. Cut all the 
tissue into 2-3mm3 pieces. Using forceps place 2-3mm3 pieces into a 50ml centrifuge tube. 
 
1.2.3. Thaw 100mg/ml stock collagenase type II and dilute 1:10 in 10ml PBS to a final 
concentration of 1mg/ml. Thaw 20,000U/ml stock hyaluronidase and dilute 1:400 to a final 
concentration of 50U/ml in the collagenase solution. 
 
1.2.4. Add enzymatic cocktail to the centrifuge tube containing the tissue fragments. Incubate 
the tissue fragments for 5hr at 37°C on a slow rotator. 
 
1.2.5. Dilute the cell suspension 1:5 in PBS. Place a 100µm pore filter into a new 50ml 
centrifuge tube. Pour the cell suspension onto the 100µm pore filter.  
 
NOTE: Remaining tissue fragments will be retained on the filter and cells will be collected in the 
50ml centrifuge tube. 
 
1.2.6. Discard the filter. Centrifuge the cell suspension at 400 x g for 10min at room 
temperature. Aspirate supernatant and resuspend WJMSC pellet in 12ml complete WJMSC 
culture medium (DMEM Low Glucose, 10% FCS and 100U/ml penicillin/100µg/ml streptomycin 
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mix). 
1.2.7. Seed all cells in a 75cm2 tissue culture flask. Change the medium after 24hr with 12ml 
complete WJMSC culture medium.  Replace medium every 2-3 days. Cells should reach 70-80% 
confluence within 2 weeks. Passage when WJMSC reach 70-80% confluence (see Section 1.4.).  
 
1.3. Expansion of bone marrow-derived MSC (BMMSC)  
 
1.3.1. Isolate human bone marrow-derived MSC (BMMSC) as previously described24. Add 10ml 
pre-warmed MSC growth medium (MSCGM) into a 15ml centrifuge tube. 
 
1.3.2. Thaw a vial of p2 BMMSC by placing in a 37°C water bath for 2min. Add the BMMSC 
suspension to the centrifuge tube containing MSCGM. Mix well by pipetting. 
 
1.3.3. Centrifuge at 400 x g for 5min at room temperature. Aspirate supernatant completely.  
 
1.3.4. Resuspend cells in 1ml MSCGM and count the cells using a haemocytometer or a digital 
cell counter such as a cellometer.  
 
1.3.5. Seed cells into 75cm2 culture flasks at a density of 5,000-6,000 cells per cm2 in 12ml 
MSCGM. Change the medium after 24hr with 12ml MSCGM.  Feed cells with 12ml MSCGM 
every 2-3 days. 
 
1.3.6. Passage when BMMSC reach 70-80% confluence (see Section 1.4.). Cells exhibit a 
fibroblastic morphology (Figure 1Aii). 
 
1.4. Detachment of EC and MSC  
 
1.4.1. Aspirate medium from 25cm2 culture flasks. Add 2ml of 0.02% EDTA for approximately 
2min. Aspirate EDTA and add 2ml trypsin (2.5mg/ml).  View under the microscope until the cells 
become round. 
 
1.4.2. Tap the flask to detach the cells.  Inactivate the trypsin by adding 8ml culture medium 
(dependent on cell type; EC medium for HUVEC, DMEM LG for WJMSC and MSCGM for 
BMMSC) to the culture flask and transfer suspension to a 15ml centrifuge tube. 
 
1.4.3. Centrifuge at 400 x g for 5min at room temperature. Aspirate supernatant and 
resuspend the pellet as described below. 
 
1.4.3.1. For passaging of MSC, resuspend pellet in 3ml culture medium.  Add 11ml 
culture medium into three separate 75cm2 culture flasks.  Add 1ml cell suspension to each 
culture flask (1:3 split). Passage WJMSC and BMMSC 3 times (p3) before use in co-culture 
assays. 
 
1.4.4. For seeding EC or MSC in adhesion assays – see Sections 2 and 3. 
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1.5. Freezing MSC 
 
1.5.1. At passage 3 detach MSC as described in Section 1.4. Aspirate supernatant and 
resuspend in 3ml ice-cold CryoSFM.  Pipette 1ml aliquots of cell suspension into 1.5ml ice-cold 
cryovials. Put cryovials in a freezing container. 
 
1.5.2. Store the container at -80°C overnight. Transfer to liquid nitrogen. Thaw vial of MSC 
(follow steps 1.3.1-1.3.6. in Section 1.3.). Resuspend MSC in 5ml culture medium (choose 
appropriate medium for WJMSC or BMMSC) and seed into a 25cm2 flask. 
 
2. Establishing endothelial-mesenchymal stem cell co-cultures on Ibidi microslides  
 
2.1. Trypsinise a confluent 25cm2 flask of EC (~1.5x106 cells; as Section 1.4.). Resuspend EC in 
380µl MSCGM (1x25cm2 flask will seed two 6-channel Ibidi microslides (~1.25x105/channel), for 
adhesion assays all cell types are cultured in MSCGM). Add 30µl of EC suspension to each 
channel (this will cover the growth area through capillary action). Incubate Ibidi microslide at 
37oC and 5% CO2 for 1h. 
 
2.2. Add 140µl MSCGM to each channel and then aspirate it off. Repeat twice for a total of 
three washes. Add 140µl MSCGM and place in the incubator at 37oC and 5% CO2 for 24hr. 
 
2.3. For co-cultures detach MSC (Section 1.4.). Perform a cell count using a haemocytometer 
or a cellometer. Adjust the concentration of MSC to 1.5x105 cells/ml. 
 
2.4. Aspirate excess medium from the Ibidi channels (leaving only the growth area of the 
channel in medium).Add 30µl of MSC suspension to the Ibidi channels. Aspirate the medium 
that was ejected from the growth area of the channel and add another 30µl of MSC suspension. 
Repeat once more and then place the Ibidi microslide in the incubator at 37oC and 5% CO2 for 
1h. 
 
2.5. Add 140µl MSCGM to each channel and then aspirate it off. Repeat twice for a total of 
three washes. Add a final volume of 140µl MSCGM to each channel and place in the incubator 
at 37oC and 5% CO2 for 24h. 
 
2.6. Thaw 1x105U/ml stock TNFα and dilute 1:1000 in MSCGM to a final concentration of 
100U/ml (equivalent to ~10ng/ml). Perform a serial dilution by diluting 100U/ml TNFα by 1:10 
in MSCGM to obtain 10U/ml. Dilute 10U/ml TNFα by 1:10 in MSCGM to obtain 1U/ml.  
 
2.7. Treat channels with TNFα at 37°C for 4hr prior to the assay. Temperature fluctuations 
during the cytokine treatment will alter the patterns of neutrophil recruitment observed. Add 
fresh MSCGM to untreated channels.  
 
3. Establishing endothelial-mesenchymal stem cell co-cultures on filters 
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3.1. Detach WJ or BMMSC as described in Section 1.4. Resuspend the pellet in 1ml MSCGM. 
Perform a cell count cells using a haemocytometer or a cellometer.  
 
3.2. Adjust volume so that the final concentration is 5x105 MSC in 500µl of MSCGM. 
 
3.3. Using sterile forceps invert 6-well, 0.4µm PET Transwell filters and place in a sterile box.  
3.4. Seed 5x105 MSC onto the outer surface of the filters. Incubate filters at 37oC and 5% CO2 
for 1h. 
 
3.5. Collect media from the outer surface of the filter. Count the number of non-adherent 
MSC in the media. Re-invert filters using sterile forceps and place in a matching 6-well plate 
containing 3ml MSCGM.   
 
3.6. Add 2ml of MSCGM onto the inner surface of the filter (Figure 1B). Place in an incubator 
at 37oC and 5% CO2 for 24hr. Trypsinise a confluent 25cm
2 flask of EC (Figure 1Ai; as Section 
1.4.).  
 
3.7. Resuspend EC in 8ml MSCGM (1x25cm2 flask will seed four 6-well filters; ~5x105 
EC/filter).  Aspirate medium from the top and bottom of the porous filters. Add 3ml fresh 
MSCGM into the lower chamber (underneath the filter). Add 2ml EC suspension to the inner 
surface of each filter. Incubate for 1hr at 37oC and 5% CO2.  
 
3.8. Aspirate medium to wash off non-adherent EC and replace with fresh MSCGM. Set up 
parallel EC mono-culture filters by seeding cells on the inner surface without first seeding MSC. 
Incubate overnight at 37oC and 5% CO2. 
 
3.9. Check that the EC monolayer is confluent and contains no gaps. Sub-confluent 
monolayers cannot be used for adhesion assays (Figure 1B). 
 
3.10. Treat the upper and lower chambers of the filters with 1, 10 or 100U/ml TNFα 
(equivalent to ~10ng/ml) at 37°C for 4hr prior to the assay (described in Section 2).  
 
4. Isolation of leukocytes 
 
4.1. Take venous blood from healthy volunteers and aliquot immediately into EDTA tubes. 
Invert tubes gently to mix. 
 
4.2. Layer 2.5ml Histopaque 1077 onto 2.5ml Histopaque 1119 in a 10ml round bottomed 
tube. Layer 5ml whole blood onto the Histopaque gradient. Centrifuge at 800 x g for 40min at 
room temperature. 
 
4.3. Harvest peripheral polymorphonuclear neutrophils (PMN) at the interface of Histopaque 
1077 and 1119 (above the erythrocyte layer). Place in a 10ml round bottomed tube and make 
up to 10ml with PBSA. Gently invert tube and centrifuge at 400g for 5min at room temperature. 
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4.4. Dilute 7.5% BSA solution 1:50 in 100ml PBS (with Calcium and Magnesium Chloride) to a 
final concentration of 0.15% (w/v; PBSA).  Aspirate supernatant and resuspend in 10ml PBSA. 
Centrifuge at 400 x g for 5min at room temperature. 
 
4.5. Resuspend in 1ml PBSA. Take a 20µl aliquot of the cell suspension and add to 380µl 
PBSA (1:20 dilution). Count cells using a haemocytometer or a cellometer. Dilute to the 
required concentration (2x106/ml for Transwell filters and 1x106/ml for Ibidi microslide) in 
PBSA.  Maintain neutrophil suspension at room temperature until the assay. 
 
5. Assembling the flow system 
 
5.1. Set up the flow system as shown in Figure 1C. Turn on the heater and set to 37oC. 
Attach a 20ml syringe (remove the plunger) and a 5ml syringe to a 3-way tap. Attach the tap to 
the Perspex chamber using Micropore tape. 
 
5.2. Measure and cut a long piece of silicon 2/4mm (thick) tubing that is approximately the 
distance between the valve and the 3 way tap. Cut an 8-10mm long piece of 1/3mm (thin) 
tubing and insert into one end of the thick tubing. Attach the thick tubing side onto the 3-way 
tap. 
 
5.3. Connect the thin tubing end onto a port of the electronic 3-way microvalve. This is the 
“wash reservoir”. Cut a 6-8mm long piece of thick and thin tubing.  
 
5.4. Insert the thin tubing into one end of the thick tubing. Attach the thick tubing end onto 
a 2ml syringe (remove the plunger). 
 
5.5.  Connect the thin tubing end of the 2ml syringe onto a port on the electronic microvalve 
to make the “sample reservoir”. Connect the valve to the filter flow chamber by measuring and 
cutting a long piece of thin tubing that is the distance between the microvalve and the centre of 
the microscope stage. 
 
5.6. For the microslide model, attach an 8-10mm piece of thick tubing to the end of the thin 
tubing. Place an L shaped connector to the end of the thick tubing. This will connect to the 
microslide.  For the filter model, attach an 8-10mm piece of Portex Blue Line Manometer 
connecting tubing to the end of the thin tubing.  
 
5.7. Place the thin tubing end onto the microvalve. This is the common output for the wash 
and sample reservoirs. Fill reservoirs with PBSA. Prime tubing by flowing PBSA through them to 
remove any air bubbles. 
 
5.8. Attach Manometer tubing to a 29mm (50ml) glass syringe. Prime the syringe by filling 
with 10ml PBSA. Invert the syringe so that the end connected to the tubing faces upwards and 
push out all air bubbles. Refill with 5ml PBSA. 
 
   
9 
 
5.9. For the microslide model only, attach a 10-12mm piece of thick tubing to the end of the 
Manometer tubing leading to the glass syringe. Place an L shaped connector onto the end of 
the thick tubing. Place the glass syringe into a syringe pump for infusion/withdrawal. 
 
5.10. Calculate the refill flow rate (Q) required to generate the desired wall shear stress (w in 
Pascal, Pa) of 0.1Pa (Transwell filters) or 0.05Pa (Ibidi microslides) using the following formulae: 
 
w = (6.Q)/(w.h
2) 
 = n. 
 
Where w = internal width and h= internal depth of the flow channel. n = viscosity (n) of the 
flowing solution, PBSA is n=0.7mPa.s. For the parallel plate filter flow chamber, the width (w) is 
4mm and the depth (h) is 0.133mm. The depth of the chamber can vary slightly due to 
differences in the thickness of the parafilm gasket used. For the Ibidi microslide, the width is 
3.8mm and the depth is 0.4mm.  
 
NOTE: Due to differences in the dimensions of the flow channel, and capture dynamics we use 
different shear stresses for the microslide model compared to the filter model6.    
 
6. Setting up the parallel plate flow chamber incorporating filters  
 
6.1. Cut a piece of parafilm (the same size as the glass coverslip) using a metal template. Cut 
out a 20x4mm slot in the parafilm (to create the flow channel) using a metal template. Use the 
gasket to mark the flow channel on the glass coverslip. 
 
6.2. Align the edges of the 6-well filter on the glass coverslip. Ensure that the filter covers 
the flow channel markings.  Carefully cut out the filter using a type 10A scalpel. 
 
6.3. Carefully cover the filter with a parafilm gasket, ensuring that the flow channel slot is in 
the middle of the filter (Figure 1D). Use a piece of clean tissue and push out any bubbles. 
 
6.4. Place the coverslip in the recess of the bottom plate of the Perspex flow chamber. 
Position the top Perspex plate over the top of the gasket and screw the plates together (Figure 
1D).  
 
6.5. Turn the 3-way tap to allow wash buffer (PBSA) to flow through the valve. Connect 
Manometer tubing to the inlet port of the top Persex plate. Run PBSA through the flow channel 
to allow bubbles to pass through. 
 
6.6. Connect the Manometer tubing from the syringe pump into the outlet port of the 
Perspex plate. Set the syringe pump to refill and press run. Clean any PBSA that has dripped 
onto the upper plate of the chamber. 
 
6.7. Place the chamber on the stage of an invert phase-contrast microscope. Adjust focus to 
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visualize the EC above the filters (Figure 1B). 
 
7. Setting up microslides for flow 
 
7.1. Place the microslide onto the stage of an invert phase contrast microscope. Connect the 
L shaped connector into the inlet port of a channel. Run PBSA through the flow channel. 
 
7.2. Place the L shaped connector from the syringe pump into the outlet port of the channel. 
Set the syringe pump to refill and press run. Clean any PBSA that has dripped onto the 
microslide. Adjust focus to visualize the EC monolayer. 
 
8. Perfusion of leukocytes over endothelial cells. 
  
8.1. Put 2ml of purified neutrophils into the sample reservoir and leave to warm for 2min. 
Wash the endothelium with PBSA for 2min.  
 
8.2. Turn the valve ON to perfuse neutrophils over endothelium. Deliver the neutrophil bolus 
for 4min. Turn the valve OFF and perfuse PBSA from the wash reservoir for the remainder of 
the experiment. 
 
8.3. Ensure that air bubbles do not pass through the flow channel at any point during the 
assay as this will disrupt the EC monolayer and cause detachment of adherent neutrophils. 
 
9. Recording neutrophil capture and behavior 
 
9.1. Record Neutrophil recruitment either during neutrophil flow or post-perfusion. 
 
9.2. Make all digital recordings of at least 5-10 fields in the center of the flow channel. 
Identify the center of the channel by moving the objective to the edge of the channel at the 
inlet port and identifying the middle of the port.  
 
9.2.1. For recording during neutrophil flow, take images of a single field every 10sec for 1min. 
Move along the channel and record another field for 1min.  Repeat for duration of bolus. 
 
9.2.2. For recording post-perfusion, make 10sec recording of 5-10 fields down the centre of 
the flow channel for assessing leukocyte behavior (typically 2min after the end of the 
neutrophil bolus). Take images every second within the 10sec interval. This allows sufficient 
time for capture from flow and the behavior of adherent neutrophils to be analyzed.  
 
9.2.3. Record a single field containing at least 10 transmigrated neutrophils for 5min, taking 
images every 30sec. This can be used to calculate the velocity of migrated cells (either above or 
underneath the endothelium). 
 
9.2.4. Record another series of 10sec fields (typically 9min post-perfusion). This allows 
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neutrophils time to migrate through the endothelial monolayer. 
 
9.2.5. Stop the syringe pump and remove the tubing. Disassemble the flow chamber and rinse 
the sample reservoir and tubing. Repeat for subsequent filters/microslide channels. 
 
10. Analysis of leukocyte recruitment and behavior 
10.1. Count the number of neutrophils in each field during the 10 second recordings at the 
2min time point. All cells must be present throughout the 10 second recording to be counted; 
as such cells that enter or leave part way through (e.g. at 9sec) are not included. Cells that are 
partially in the field on 2 sides (e.g. top/right hand border) of the field of view are included in 
the counts, as long as they remain in the field for the full 10 seconds. 
 
10.2. Calculate the mean number of adherent neutrophil per field. Measure the length and 
width of the recorded field. Calculate the area of the field. Calculate how many fields there are 
in 1mm2.Multiply the mean neutrophil count by the number of fields in 1mm2. 
 
10.3. Calculate the total number of neutrophils perfused by multiplying the amount of 
neutrophils perfused (e.g. 2x106/ml*Q [e.g.0.0999ml/min for parallel plate flow chamber]) by 
the duration of the bolus (e.g. 4min). 
 
10.4. Divide the neutrophil count/mm2 by the total number of neutrophils perfused to 
determine the total number of cells that have adhered (adherent cells/mm2/ 106 perfused). 
 
10.5. Assess whether the adherent neutrophils are rolling, firmly adherent or transmigrated 
(Supplementary Video 1 and 2). 
 
10.5.1. A rolling neutrophil is phase bright and will slowly move along the endothelial 
monolayer (1-10µm/s; Supplementary Video 1).  
 
10.5.2. Firmly adherent cells are phase bright and bound to the EC surface, either remaining 
stationary (i.e. not moving during recording) or have undergone shape change and are 
migrating over the EC surface (Figure 1Ei).  
 
10.5.3. A transmigrated neutrophil is phase dark and below the EC layer (Figure 1Eii). 
 
10.6. Calculate the percentage of adherent cells that are rolling, stationary and transmigrated. 
Alternatively, neutrophil behavior can be expressed as total cell numbers that exhibit the 
different behaviors by applying the same formula used to calculate total adhesion (as described 
in 10.6-10.7). 
 
10.6.1. Mark the leading edge of a rolling neutrophil. Mark the leading edge of the same cell at 
the end of the 10sec sequence. Draw a line between the two points and measure the distance 
that the cell has travelled. 
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10.6.2. Divide this value by the duration of the recording in which the cell is rolling (i.e. 10sec). 
Try and select neutrophils that are in the field for the entire 10sec interval. 
 
10.7. To calculate the velocity of neutrophils migrating over the surface (shaped changed 
phase bright) or underneath the endothelium (phase dark) use the 5min recording 
(Supplementary Video 2). 
 
10.7.1. Draw an outline of migrated cells at the beginning of the sequence and track their 
movements throughout the sequence. Make note of the X and Y positions of the centroid at 
each 30sec interval for each cell. Subtract values of the X and Y position from the first image of 
the sequence from the values in the second image. This is based on Pythagoras’ theorem. 
 
10.7.2. Subtract the values from the second image from the third image. Do this for all images 
in the sequence. Square the X and Y values and add them together.  
 
10.7.3. Square root the resulting value. Calculate the velocity for each cell by averaging the 
velocities calculated at each minute interval. Track 10 migrated neutrophils and calculate the 
mean velocity. 
 
REPRESENTATIVE RESULTS:  
Initially, we analyzed the effect of stimulating EC with TNFα on the recruitment of neutrophils 
from flow using the Ibidi microslide model (Section 7-9). In the absence of TNFα, little if any 
neutrophils adhered to the endothelial monolayer (Figure 2A). This was expected, as 
untreated/resting EC do not express the necessary adhesion molecules (selectins) or 
chemokines to support binding25,26. In contrast, cytokine-stimulation significantly increased 
neutrophil adhesion to the endothelium in a dose-dependent manner (Figure 2A). Adhesion 
normally remains stable over the course of the assay. Binding of leukocytes to untreated 
endothelium indicates that either the EC are activated (i.e. contaminated with LPS during the 
culture process) and/or the neutrophils were activated during the isolation process. Indeed, LPS 
has been shown to increase the expression of E-selectin, ICAM-1 and VCAM-125-27 on the 
surface of EC, allowing them to bind neutrophils. 
 
When analyzing the behavior of the recruited neutrophils we typically observe a dose-
dependent decrease in the percentage of neutrophils rolling (Figure 2B) with a concomitant 
dose dependent increase in the percentage of neutrophils migrating through the endothelial 
monolayer (Figure 2C). At the lower doses of TNFα-stimulation (1U/ml) a larger proportion of 
neutrophils appear phase bright indicating that they are attached to the apical surface of the 
endothelium (Figure 2B). In contrast, at 10 and 100U/ml (higher doses) approximately 40% of 
the recruited neutrophils appear phase dark at 2min indicating that these cells have migrated 
through the endothelial monolayer and are underneath the endothelium (Figure 2C). 
Neutrophils are able to migrate through the EC within 1-2min, with transmigration reaching 
maximal levels at ~10min post-perfusion28. Here we observed an increase in neutrophil 
transmigration from 40% at 2min to 60% by 9min post perfusion (Figure 2C). We observed no 
effect of TNFα concentration on the velocity of rolling (~3µm/sec) or migrating (~10-12µm/min) 
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neutrophils.  
 
In the filter based model, TNFα-stimulation increased neutrophil adhesion in a dose-dependent 
manner similar to that seen using the Ibidi microslide model (Figure 3A). In terms of behavior, 
neutrophil rolling was unaffected by TNFα dose (Figure 3B), whilst a dose-dependent increase 
in percentage transmigration was observed (Figure 3C). In this series of experiments we 
observed no significant effect of time on neutrophil transmigration (Figure 3C).  
 
We provide methods on how to generate two different co-culture constructs, each of which is 
devised to answer specific questions. In the ibidi microslide model, EC and MSC are cultured in 
a single monolayer in direct contact with one another. This model is useful for examining the 
effect of therapeutic injection of MSC into the blood and their subsequent integration into the 
EC monolayer. In contrast in the filter-based model, EC and MSC are cultured on opposite sides 
of the filter in close proximity but not necessarily in direct contact. This more closely resembles 
tissue, with endothelial cells forming a monolayer representing the blood vessel, and MSC 
residing in the subendothelial compartment. This allows us to examine the effects of tissue-
resident MSC on the response of EC to cytokine stimulation.   
 
Based on our experiences, we observe that maximal neutrophil recruitment and 
transendothelial migration occurs when EC are stimulated with 100U/ml TNFα. As such, we 
have used this concentration to examine the effect of MSC co-culture on endothelial 
recruitment of neutrophils from flow. Here, we present data for BMMSC in co-culture with EC 
using the microslide and filter-based models however, other types of MSC can also be 
examined e.g. WJMSC.  In both models the presence of BMMSC significantly reduced neutrophil 
adhesion to the EC when compared to EC cultured alone (Figure 4A). Co-culture had no effect 
on the behavior of recruited neutrophils, with similar levels of rolling and transmigration 
observed on EC cultured alone or with MSC (Figure 4B and C). Thus, MSC can modify the EC 
response to cytokine stimulation, which suppresses their ability to support neutrophil 
recruitment from flow.  
 
FIGURE LEGENDS:  
Figure 1: Establishing EC-MSC co-culture and analyzing neutrophil recruitment using a flow-
based adhesion assay.  
(A) Micrograph of (i) primary EC and (ii) passage 3 BMMSC grown on tissue culture flasks. (B) 
Micrograph of EC and MSC cultured on 6-well Transwell filter inserts. (C) Diagram of the 
perfusion system used to generate flow. (D) Schematic representation of the parallel plate filter 
flow chamber. (E) Micrograph of (i) firmly adherent (FA) and (ii) transmigrated (TM) neutrophils 
following recruitment from flow to EC stimulated with 100U/ml TNFα. Images C and D are 
taken from Figures 2 and 3 in Methods in Molecular Biology: T-cell Trafficking, 2010, pages 53-
428 with kind permission from Springer Science and Business Media.  
 
Figure 2: Neutrophil recruitment from flow to TNF-stimulated EC using Ibidi microslides. 
EC were stimulated with increasing concentrations of TNFα (0-100U/ml) for 4hr. A 4min bolus 
of neutrophils was perfused over the EC monolayer at 0.05Pa. (A) Neutrophil adhesion assessed 
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at 2min. ANOVA showed a significant effect of TNFα treatment on neutrophil adhesion, p<0.01. 
Neutrophil behavior was assessed at 2 and 9min and expressed as a percentage of adherent 
cells that were (B) rolling or (C) transmigrated. ANOVA showed a significant effect of TNFα 
treatment on the behavior of the adherent neutrophils, p<0.001. In C, ANOVA showed a 
significant of time on transmigrated neutrophils p<0.01. Data are mean ± SEM from n=3 
experiments. *p<0.05 and **p<0.01 compared to the unstimulated (0U/ml) EC control by 
Dunnett post-test.  ##p<0.01 and ###p<0.001 compared to the 1U/ml EC at the same time point 
by Bonferroni post-test. 
 
Figure 3: Neutrophil recruitment from flow to TNF-stimulated EC using filter-based assay.  
EC were stimulated with increasing concentrations of TNFα (0-100U/ml) for 4hr. A 4min bolus 
of neutrophils was perfused over the EC monolayer at 0.1Pa. (A) Neutrophil adhesion assessed 
at 2min. ANOVA showed a significant effect of TNFα treatment on neutrophil adhesion, 
p<0.001. Neutrophil behavior was assessed at 2 and 9min and expressed as a percentage of 
adherent cells that were (B) rolling or (C) transmigrated. In C, ANOVA showed a significant 
effect of time and cytokine treatment on neutrophil transmigration, p<0.05. Data are mean ± 
SEM from n=3 experiments. **p<0.01 and ***p<0.001 compared to the unstimulated (0U/ml) 
EC control by Dunnett post-test. #p<0.05 compared to the 1U/ml EC at the same time point by 
Bonferroni post-test. 
 
Figure 4: Neutrophil recruitment from flow to TNF-stimulated EC-BMMSC co-cultures. 
BMMSC were co-cultured with EC for 24hr prior to stimulation with 100U/ml TNFα for 4hr. A 
4min bolus of neutrophils was perfused over the EC monolayer at 0.05Pa for (A, C, E) 
microslides and 0.1Pa for (B, D, F) filters. (A-B) Neutrophil adhesion was assessed at 2min. 
Neutrophil behavior was assessed at 2 and 9min and expressed as a percentage of adherent 
cells that were (C-D) rolling or (E-F) transmigrated. In C and D, ANOVA showed a significant 
effect of culture conditions on neutrophil rolling, p<0.05. In E and F, ANOVA showed a 
significant effect of time on neutrophil transmigration, p<0.05. However, no significant 
differences were observed in transmigration between individual treatments by Bonferroni post-
test. Data are mean ± SEM from n=5 experiments. *p<0.05 compared to the EC monoculture by 
paired t-test or Bonferroni post-test.  
 
Supplementary Video 1: Analysis of neutrophil rolling velocities. 
EC cultured on a Transwell filter were stimulated with 100U/ml TNFα for 4hr. A bolus of 
neutrophils was perfused over the EC for 4min. Representative digitized sequence of a single 
10sec field taken 2min post-perfusion. The change in position of a single rolling neutrophil from 
the beginning to the end of the 10sec sequence can be used to calculate the velocity at which 
the neutrophil is rolling. 
 
Supplementary Video 2: Analysis of neutrophil migration velocities. 
EC cultured on a Transwell filter were stimulated with 100U/ml TNFα for 4hr. A bolus of 
neutrophils was perfused over the EC for 4min. Representative digitized sequence of a single 
5min field to track the movement of transmigrated neutrophils. This can be used to calculate 
the velocity. 
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DISCUSSION:  
Here we describe two in vitro “vascular” models for studying the recruitment of circulating 
neutrophils by inflamed endothelium. A major advantage of these models is the ability to 
analyze each step in the leukocyte adhesion cascade in order, as would occur in vivo. We have 
previously observed a dose-dependent increase in neutrophil adhesion to and transmigration 
through TNFα-stimulated EC9,29.  We also describe how both models can be adapted to study 
the effects of stromal cells on leukocyte recruitment. Here, MSC were co-cultured with EC in an 
Ibidi microslide or on opposite sides of a porous filter. This allows both cell types to 
communicate with one another, thereby modifying each other’s phenotype and response. We 
have shown here, and in previous studies23, that the presence of MSC suppressed neutrophil 
adhesion to TNFα-stimulated EC. This indicates that stromal cells modify the EC response to 
cytokines and subsequently alters the recruitment of circulating leukocytes. 
 
In addition to the models described above, Cellix Biochips, Bioflux plates and Glyotech parallel 
plate flow chambers are commercially available flow channel systems that provide a surface for 
culturing endothelium and observing recruitment. In all systems, certain parameters should be 
considered whilst establishing endothelial cultures and performing the flow-based adhesion 
assays, some of which are highlighted below and in previous reports30,31. Any anti-inflammatory 
agents, such as hydrocortisone, that may affect the cytokine responses should be omitted from 
the medium for the duration of the culture and assay18,29. When using the Ibidi microslide 
ensure that there are no air bubbles present in the flow channel during the culture of the EC as 
these will disrupt the EC monolayer. The integrity of the endothelial monolayer should be 
confirmed prior to cytokine-treatment, as neutrophils will bind to the gaps in the monolayer 
where the BSA has coated the microslide/filter. It is also essential to ensure that EC are 
maintained at 37°C throughout the cytokine-stimulation because TNFα is temperature sensitive 
and only has the maximal effect at 37°C.  For the flow assay itself, select an appropriate wash 
buffer, we typically use PBSA for short assays (less than 30mins) and M199 medium 
supplemented with BSA (0.15%) for longer assays (1-48h)30,31. Finally ensure that there are no 
air bubbles present in the flow channel during the assay as this disrupts the flow rate, damages 
the EC monolayer and activates adherent neutrophils. 
 
One of the major advantages of the multi-cellular in vitro models described here is their ability 
to replicate the in vivo interactions between EC and stromal cells. It is difficult to isolate the 
effects of specific stromal components in vivo and to modify them in a controlled manner. In 
our models, stromal cells can be manipulated to elucidate how they communicate with EC and 
influence the inflammatory process in health and disease. For example, using siRNA technology 
we have previously shown that production of IL-6 by MSC during co-culture was necessary for 
their immunosuppressive effects23. Each model can be used to address specific questions i.e. 
the effect of tissue-resident stromal cells (filter-based model) or therapeutically administered 
stromal cells (Ibidi microslides and other commercially available systems) on leukocyte 
recruitment. In both cases we have titrated different stromal cell types to ensure their viability 
and to establish a suitable ratio of stromal cell to EC for assessing effects on recruitment15;25. 
Similarly culture medium must be compatible with each cell type incorporated into the model. 
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In our hands co-cultures are typically performed in the stromal cell medium11,18,23,31.  
 
Using the filter-based model, we have previously shown that various stromal cells modulate the 
ability of EC to support adhesion and migration of leukocytes in a tissue-specific manner and 
that these effects become altered in chronic diseases3. This led to the concept that stromal cells 
establish tissue-specific “address codes” which actively regulate the recruitment of leukocytes 
to inflamed tissue24. These models are specifically designed to examine the initial stages of 
recruitment in great detail but are unable to study the subsequent migration within the 
subendothelial space (i.e. away from the endothelium into the tissue). Multi-cellular, 
multilayered 3D constructs such as a static collagen gel assay12,32 would be more appropriate 
for studying these latter phases of recruitment.  
 
Our flow-based adhesion models are highly versatile. We have described their use in the 
context of neutrophil recruitment, but other leukocyte subsets can be investigated in a similar 
manner. We have also used the ibidi microslide system to investigate the recruitment of 
circulating MSC by EC23, and whether this occurs through the same adhesion cascade reported 
for leukocytes. Likewise these models could be used to examine the recruitment and 
incorporation of metastatic tumor cell lines, and their subsequent effects on endothelial 
responses and leukocyte recruitment. Alternatively, the filter-based model could be adapted to 
incorporate different types of stromal cells (e.g. fibroblasts, podocytes, smooth muscle cells) 
from healthy tissues13,21 and sites of disease11,18,20. This would enable the study of tissue-
specific regulatory pathways acting at the level of on EC and/or leukocytes. In all cases the 
disruption of normal regulatory processes in a range of disease conditions can be examined to 
identify key regulatory mediators (such as IL-6 and TGFβ) and potential new therapeutic 
targets.  In the context of chronic inflammation these agents might be used to switch off the 
recruitment process, whilst in cancer biology one could imagine their use to turn on 
recruitment to target the tumor.   
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